Article
Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition.
European journal of immunology - 1 Mar 2013
Khan Adnan, Fu Hongmei, Tan Lee Aun, Harper Jennifer E, Beutelspacher Sven C, Larkin Daniel F P, Lombardi Giovanna, McClure Myra O, George Andrew J T
Abstract excerpt
Dendritic cell (DC) modification is a potential strategy to induce clinical transplantation tolerance. We compared two DC modification strategies to inhibit allogeneic T-cell proliferation. In the first strategy, murine DCs were transduced with a lentiviral vector expressing CTLA4-KDEL, a fusion protein that prevents surface CD80/86 expression by retaining the co-stimulatory molecules within the ER. In the second...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
